Pharmaceutical
ChemLinkedMarketChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
Notice of NMPA on Matters related to the Registration of Drug and Device Combination Products (2021 No. 52)
Request Notice of NMPA on Matters related to the Registration of Drug and Device Combination Products (2021 No. 52)
  • Local Title:国家药监局关于药械组合产品注册有关事宜的通告（2021年第52号）
  • Country/Region:Chinese Mainland
  • Competent Authority: National Medical Products Administration (NMPA)
  • Type:Notice
  • Status:In force
  • Release Date:2021-07-27
  • Implementation Date:2021-07-27
Request
Document
Language Source Title Access
ZH Official 国家药监局关于药械组合产品注册有关事宜的通告（2021年第52号） Download
Summary

The Notice of NMPA on Matters related to the Registration of Drug and Device Combination Products (2021 No. 52) was issued on Jul.27, 2021. It aims to strengthen the registration management of pharmaceutical and mechanical combination products, which includes relevant policies, regulations, and measures.

Most Popular